Nilsson D, Fagerholm U, Lennernäs H
Department of Neurology, University Hospital, Uppsala, Sweden.
Pharm Res. 1994 Nov;11(11):1540-7. doi: 10.1023/a:1018941200575.
Food ingestion can influence the absorption of levodopa in the intestine and thereby contribute to fluctuations of motor functions in Parkinson patients. Obstruction of the active transport of levodopa by amino acids can be one factor. Paracellular drug absorption, a route proposed to be influenced by net transport of water across the intestinal epithelium, might occur for a small and hydrophilic drug such as levodopa. In the present study we studied how luminal L-leucine (60 mmol/L), alone or combined with hypotonicity, might stimulate net water absorption, and levodopa uptake in the human small intestine, since this possibly can contribute to the variable intestinal absorption of levodopa. The Loc-I-Gut perfusion technique was used in 10 healthy volunteers to study the effects of induced net fluid absorption on the small intestinal absorption of levodopa (2.5 mmol/L). An induced net fluid absorption was observed only when L-leucine was combined with a hypoosmolar perfusion solution. However, this did not enhance the intestinal permeability of levodopa. In conclusion, we suggest that the variability in the absorption of levodopa in Parkinson's disease cannot be explained by differences in transmucosal water flux in the human small intestine.
食物摄入会影响左旋多巴在肠道的吸收,进而导致帕金森病患者运动功能的波动。氨基酸对左旋多巴主动转运的阻碍可能是一个因素。像左旋多巴这样的小分子亲水性药物可能会通过细胞旁路进行药物吸收,这一途径被认为受肠道上皮细胞水的净转运影响。在本研究中,我们研究了管腔内的L-亮氨酸(60 mmol/L)单独或与低渗状态联合使用时,如何刺激人体小肠的水净吸收和左旋多巴摄取,因为这可能会导致左旋多巴在肠道的吸收存在差异。我们采用Loc-I-Gut灌注技术,对10名健康志愿者进行研究,以观察诱导性净液体吸收对左旋多巴(2.5 mmol/L)小肠吸收的影响。仅当L-亮氨酸与低渗灌注液联合使用时,才观察到诱导性净液体吸收。然而,这并未增强左旋多巴的肠道通透性。总之,我们认为帕金森病患者左旋多巴吸收的差异不能用人体小肠跨黏膜水通量的差异来解释。